360 related articles for article (PubMed ID: 30523605)
1. Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis.
Kazmi F; Soon YY; Leong YH; Koh WY; Vellayappan B
J Neurooncol; 2019 Mar; 142(1):79-90. PubMed ID: 30523605
[TBL] [Abstract][Full Text] [Related]
2. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
[TBL] [Abstract][Full Text] [Related]
3. Fractionated stereotactic re-irradiation for recurrent glioblastoma: A systematic review and meta-analysis.
Luo T; Feng J; Sun P
Clin Neurol Neurosurg; 2023 Jun; 229():107728. PubMed ID: 37105068
[TBL] [Abstract][Full Text] [Related]
4. Re-irradiation with radiosurgery for recurrent glioblastoma multiforme.
Torok JA; Wegner RE; Mintz AH; Heron DE; Burton SA
Technol Cancer Res Treat; 2011 Jun; 10(3):253-8. PubMed ID: 21517131
[TBL] [Abstract][Full Text] [Related]
5. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
Lee J; Ahn SS; Chang JH; Suh CO
Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
[TBL] [Abstract][Full Text] [Related]
7. Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept.
Bräutigam E; Lampl C; Track C; Nieder C; Pichler J; Hammer J; Geinitz H
Clin Transl Oncol; 2019 May; 21(5):582-587. PubMed ID: 30284233
[TBL] [Abstract][Full Text] [Related]
8. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
[TBL] [Abstract][Full Text] [Related]
9. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
11. Re-Irradiation for Recurrent Glioblastoma Multiforme.
Rades D; Witteler J; Leppert J; Schild SE
Anticancer Res; 2020 Dec; 40(12):7077-7081. PubMed ID: 33288605
[TBL] [Abstract][Full Text] [Related]
12. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
[TBL] [Abstract][Full Text] [Related]
13. Re-irradiation for recurrent glioblastoma multiforme: a critical comparison of different concepts.
Baehr A; Trog D; Oertel M; Welsch S; Kröger K; Grauer O; Haverkamp U; Eich HT
Strahlenther Onkol; 2020 May; 196(5):457-464. PubMed ID: 32016497
[TBL] [Abstract][Full Text] [Related]
14. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
[TBL] [Abstract][Full Text] [Related]
15. Timing of re-irradiation in recurrent high-grade gliomas: a single institution study.
Zemlin A; Märtens B; Wiese B; Merten R; Steinmann D
J Neurooncol; 2018 Jul; 138(3):571-579. PubMed ID: 29520609
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and toxicity of CyberKnife re-irradiation and "dose dense" temozolomide for recurrent gliomas.
Conti A; Pontoriero A; Arpa D; Siragusa C; Tomasello C; Romanelli P; Cardali S; Granata F; De Renzis C; Tomasello F
Acta Neurochir (Wien); 2012 Feb; 154(2):203-9. PubMed ID: 21984132
[TBL] [Abstract][Full Text] [Related]
17. Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma.
Nieder C; Astner ST; Mehta MP; Grosu AL; Molls M
Am J Clin Oncol; 2008 Jun; 31(3):300-5. PubMed ID: 18525311
[TBL] [Abstract][Full Text] [Related]
18. Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme.
Combs SE; Gutwein S; Thilmann Ch; Huber P; Debus J; Schulz-Ertner D
J Neurooncol; 2005 Sep; 74(2):167-71. PubMed ID: 16193388
[TBL] [Abstract][Full Text] [Related]
19. Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.
Krauze AV; Peters C; Cheng J; Ning H; Mackey M; Rowe L; Cooley-Zgela T; Smart DD; Camphausen K
Radiat Oncol; 2017 Nov; 12(1):191. PubMed ID: 29187219
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
Straube C; Scherb H; Gempt J; Kirschke J; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
BMC Cancer; 2018 Jan; 18(1):15. PubMed ID: 29298660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]